Mostrar el registro sencillo del ítem

dc.creatorZygogianni, A.en
dc.creatorKouloulias, V.en
dc.creatorKyrgias, G.en
dc.creatorArmpilia, C.en
dc.creatorAntypas, C.en
dc.creatorTheodorou, K.en
dc.creatorKouvaris, J.en
dc.date.accessioned2015-11-23T10:55:29Z
dc.date.available2015-11-23T10:55:29Z
dc.date.issued2013
dc.identifier10.1016/j.clbc.2013.02.007
dc.identifier.issn1526-8209
dc.identifier.urihttp://hdl.handle.net/11615/35041
dc.description.abstractThe application of the tumor bed boost by using 2 different hypofractionated planning techniques permit more efficient use of resources in hospitals. The evaluation of the radiation toxicity and the efficacy of the 2 schedules were well tolerated and effective. However, the sequential boost appears superior to the concomitant boost in terms of skin toxicity. Aim: Evaluation of related radiation toxicity and efficacy in terms of local control of 2 radiotherapeutic hypofractionated schedules in the application of tumor bed boost by using 2 different planning techniques. Method: Eighty-one patients with stage I-II disease were retrospectively selected with either concomitant (group A) or sequential (group B) boost for the tumor bed. In group A, 27 patients were treated with a total dose of 46 Gy to the whole breast and 54 Gy to the tumor bed in 20 concomitant fractions. In group B, 54 patients were treated with a total dose of 42.4 Gy in 16 fractions to the whole breast and 53 Gy to the tumor bed by 4 sequential fractions. The boost was administered with multiple photon-beam fields. The median follow-up time was 24 months. Results: The statistical analysis for the 2 groups of the study showed that skin toxicity was significantly worse in group A (P < .05, Kruskal-Wallis H test). For groups A and B at the completion of radiation therapy, grade 1 skin toxicity was observed in 18/27 patients (66.6%) and 13/54 patients (24.1%), respectively, whereas grade 2/3 was observed in 9/27 patients (33.3%) vs. 5/54 patients (9.3%), respectively (P < .001). One year after irradiation, in group A and in group B, the skin toxicity was of grade 1 in 6/27 patients (22.2%) vs. 2/54 patients (3.7%), respectively (P = .008). Within 2 years, the breast returned to its original form in all patients. No patient showed local disease recurrence. Conclusions: The accelerated hypofractionated schedules in the application of the tumor bed boost by using the 2 different planning techniques appears to be effective and well tolerated.en
dc.source.uri<Go to ISI>://WOS:000321239600010
dc.subjectBreast canceren
dc.subjectConcomitanten
dc.subjectRadiotherapyen
dc.subjectSequentialen
dc.subjectToxicityen
dc.subjectTumoren
dc.subjectbeden
dc.subjectBREAST-CONSERVING TREATMENTen
dc.subjectRANDOMIZED-TRIALen
dc.subjectCANCER RADIOTHERAPYen
dc.subjectCONSERVATIVE TREATMENTen
dc.subjectINTENSITY MODULATIONen
dc.subjectCONCOMITANT BOOSTen
dc.subjectELECTRON BOOSTen
dc.subjectACUTE TOXICITYen
dc.subjectLOCAL-CONTROLen
dc.subjectI-IIen
dc.subjectOncologyen
dc.titleComparison of Two Radiotherapeutic Hypofractionated Schedules in the Application of Tumor Bed Boosten
dc.typejournalArticleen


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem